3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Not yet recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Leukemia, Myeloid, Acute
40
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Myelodysplastic Syndromes
30
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
20
Hematologic Neoplasms
18
Hodgkin Disease
17
Lymphoma, Non-Hodgkin
16
Myeloproliferative Disorders
14
Leukemia, Lymphocytic, Chronic, B-Cell
13
Leukemia, Biphenotypic, Acute
13
Leukemia
13
Graft vs Host Disease
13
Leukemia, Myelomonocytic, Chronic
11
Anemia, Refractory, with Excess of Blasts
11
Multiple Myeloma
10
Lymphoma
10
Primary Myelofibrosis
9
Lymphoma, Mantle-Cell
7
Lymphoma, Follicular
7
Lymphoma, B-Cell, Marginal Zone
6
Leukemia, Prolymphocytic
6
Waldenstrom Macroglobulinemia
5
Lymphoma, Large B-Cell, Diffuse
5
Hematologic Diseases
5
Burkitt Lymphoma
5
Anemia, Aplastic
5
Polycythemia Vera
4
Myelodysplastic-Myeloproliferative Diseases
4
Leukemia, Myeloid
4
Blast Crisis
4
Interventions
vedolizumab
1
Surveys and Questionnaires
1
Photopheresis
1
Phlebotomy
1
Mycophenolic Acid
1
Methoxsalen
1
Infliximab
1
Blood Specimen Collection
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hepatitis
×
Mycophenolic Acid
×
1 year
×
Clear all
NCT07619898
2026-06-02
PHOENIX-ECP
Therakos LLC
Phase 2
Not yet recruiting
112 enrolled